LOP_tianno



CURRICULUM VITAE- Howard Amital MD MHAnameHoward Amital (Teplizki) MD MHA 13323324 (First)(Last)Academic DegreeID No.faculty/deptSenior lecturer, Sackler Faculty of Medicine, Tel-Aviv University (2007).Head of Assessment committee, Sackler Faculty of Medicine, Tel-Aviv University (2007). (??"? ???? ??????)Member of the clinical teaching committee, Sackler Faculty of Medicine, Tel-Aviv University (2008) (??? ???? ????? ???????? ???????)Head of subcommittee of the scientific consulate of the Israeli Medical Association (2009) hospital/dept3.2011 – Head of Department of Medicine 'B', Sheba Medical Center, Tel-Hashomer11.2005-2.2011, Head of Department of Medicine 'D', Meir Medical Center, Tshernichovski st. 59, Kfar-Saba, 44281Tel. No.03-5302652home addressHadror 2, Gadera 70700Tel. No.08-9700616date and place of birthdate of arrival in israel4th of June, 1964, Canada(date, country)12/1970zahal (israeli) military service1989, Lieutenant Colonel, Medical Corps (Reserves).Retirement from military service 1.1.2008marital statusNo. of childrenMarried, five childrena. EducationPeriod of Study (dates) FORMTEXT Medical school, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel 1981-1987Medicine(Subject)MD (Degree or Professional License) 1987(Date Awarded)Title of Doctoral DissertationNames of SupervisorsDoes platelet derived growth factor (PDGF) induce myelofibrosis in agnogenic myeloid metaplasia? (Title)Prof. Dvilnasky, Soroka Medical Center, Ben-Gurion University of the Negev b. further studiesMasters of Health Administration (MHA)Period of Study (dates)School of Management , Ben-Gurion University of the Negev, Beer-Shava, 2001-2002 c. academic and professional experience(for mds – ACADEMIC EXPERIENCE; CLINICAL EXPERIENCE)7-10/19861993-19992001-2004SouthWest Foundation of BioMedical Research, San-Antionio, Tx, USA. Analysis of idiotypes and antiidiotypes in autoimmune diseases. Department of Virology and Immunology.Internal Medicine Residency, Sheba Medical Center, Tel-HashomerRheumatology Fellowship, Hadassah Medical Center, Ein-Carem, Jerusalem11.2005-3.20113.2011-Head of the Dept. of Medicine 'D', Meir Medical Center, Kfar-Saba.Head of the Dept. of Medicine 'B', Sheba Medical Center, Tel-Hashomer.d-1. active participation in scientific meetingsYearName of Meeting, City, Country1987Shoenfeld Y,Teplizki H, Buskila D, Koike T, Coates ARM, Isenberg D, Horowitz J, Sukenik S. Mycobacterial antigens and autoimmune diseases. ARA Conference 1987, Arthritis Rheum 30:S68:B70 (Poster)1991Amital-Teplizki H, Avinoach I, Kooperman, Blank M, Shoenfeld Y. Binding of monoclonal anti-DNA and anti-TB glycolipids to brain tissue. Third International Congress on Neuroimmunology, Jerusalem, Israel (oral presentation)1995Levy Y, Ziporen L, Adler Y, Gilburd B, Amital H, Polak-Charcon S, Cledes J, Youinou P, Shoenfeld Y. Renal involvement in antiphospholipid syndrome-description of six patients and induction of renal injury in SCID mice. Fourth International Conference on SLE, Jerusalem, Israel (oral presentation)1999Amital H, Levy Y, Davidson C, Lundberg I, Harju A, Kosach Y, Asherson RA, Shoenfeld Y. Catastrophic antiphospholipid syndrome: Remission following leg amputation in 2 cases. Annual meeting of the Israeli society of Rheumatology , Israel (oral presentation)1999Amital H, Levy Y, Rewald E, Bar-Dayan Y, Manthorpe R, Engervall P, Sherer Y, Langevitz P, Shoenfeld Y. Fibrosis regression induced by intravenous gammaglobulin therapy. Annual meeting of the Israeli society allergy and clinical immunology (oral presentation)2000Amital H, Reifen R, Blank M, Sklan D, Berkovich Z, Gershwin E, Shoenfeld Y. Linseed oil suppresses the anti-cardiolipin antibodies in experimental antiphospholipid syndrome. Annual meeting of the Israeli society of Rheumatology, Israel (oral presentation)2001Amital H. Medical relief missions, the experience of the IDF Medical Corps, Israel (oral presentation)2002Amital H, Levy Y, Langevitz P, Rubinow A, Shoenfeld Y. Leg amputation –possible therapeutic role in catastrophic anti-phospholipid syndrome (CAPS)? 10th International Congress on Antiphospholipid Antibodies. Taromina, Italy2002Amital H, Gilburd B, Levy A, Shoenfeld Y. Probiotic supplementation with Lactobacillus casei (Actimel) induces a Th1 response in an animal model of the antiphospholipid syndrome. Annual meeting of the Israeli society of Rheumatology, Israel (oral presentation)2003Amital H, Gilburd B, Levy A, Shoenfeld Y. Probiotic supplementation with Lactobacillus casei (Actimel) induces a Th1 response in an animal model of the antiphospholipid syndrome. EULAR, Lisbon, Portugal (poster)2003Amital H, Aamar S, YH Applabaum, Rubinow A. SAPHO syndrome treated with pamidronate – an open labeled study in 8 patients. European League Against Rheumatism (EULAR) Lisbon, Portugal (poster)2003Amital H, Aamar S, YH Applabaum, Rubinow A. SAPHO syndrome treated with pamidronate – an open labeled study in 8 patients. Orlando, USA. American College of Rheumatology, ACR, 2003 (poster). 2003Naparstek Y, Szafer F, Ulmansky R, Heilweil M, Foster M, Mostoslavsky G, Eilat D, Pizov H, Amital H. Treatment With a Laminin-Derived Peptide Suppresses Lupus Nephritis, ACR, Orlando, USA (oral presentation)2004Amital H, Amital D, Fostick L, Pollack M, Segev S, Zohar J, Rubinow A. Fibromyalgia in men and the Post-Traumatic Stress Disorder. European League Against Rheumatism (EULAR) Berlin, Germany (oral presentation).2004Amital H, Aries PM, Lane SE on behalf of EURORITS, working party on Education An analysis of training curriculums throughout Europe: Report of European Trainee Survey of the EURORIT (European Rheumatologists in training) European League Against Rheumatism (EULAR) Berlin, Germany (oral presentation). 2004Amital H, Amital D, Fostick L, Pollack M, Segev S, Zohar J, Rubinow A.. What causes fibromyalgia? Comparing the impact of Post-Traumatic Stress Disorder and depression on the development of fibromyalgia in men. San-Antionio, USA. American College of Rheumatology, ACR (oral presentation). 2004Amital H, Barak V, Winkler RE, Rubinow A. Impact of treatment with infliximab on serum cytokine concentration in patients with rheumatoid arthritis (RA). Annual meeting of the Israeli society of Rheumatology, Israel (poster)2005Amital H, Fostick L, Amital D, Zilberman A, Zohar J, Rubinow A. Protective aspects of physical activity on male patients with post traumatic stress disorder and fibromyalgia. European League Against Rheumatism (EULAR) Vienna, Austria (poster)2005Amital D, Fostick L, Silberman A, Herskovitz C, Doron Y, Zohar J, Itsekson A, Rubinow A, Amital H. Hormonal PTSD? Aspect of tenderness in patients with the premenstrual syndrome. Annual meeting of the Israeli society of Rheumatology, Israel (poster)2006Amital D, Fostick L, Silberman A, Herskovitz C, Doron Y, Zohar J, Itsekson A, Rubinow A, Amital H. Hormonal PTSD? Aspect of tenderness in patients with the premenstrual syndrome. ACR, Washington DC. (poster)2006Amital H, Heilweil M, Ulmansky R, Toubi E, Naparstek Y. A Laminin Epitope Vrt101 Serves as a Target in Human Lupus Nephritis. ACR, Washington DC. 2006Amital H, Szekanecz Z, Szücs G, Dankó K, Nagy E, Csépány T, Orbach H, Zandman-Goddard G, Corocher N, Shoenfeld Y. Low serum concentrations of 25 OH Vitamin D in patients with autoimmune diseases. 5th International Congress on Autoimmunity. Sorrento Italy (oral presentation)2007H. Amital, M. Heilweil, R. Ulmansky, M. Harlev, E. Toubi, Y. Naparstek . A LAMININ EPITOPE VRT101 SERVES AS AN TARGET IN HUMAN LUPUS NEPHRITIS. EULAR, Barcelona2007Z. Dovrish, T. Vishne2, D. Amital, A. Rubinow, H. Amital. FIBROMYALGIA AMONG MAJOR DEPRESSION DISORDER FEMALES COMPARED TO MALESEULAR, Barcelona (poster)2007H. Amital, H. Orbach, G. Zandman-Godard, Z. Szekanecz, G. Szuc, K. Danko, T. Csepany, E. Kiss, S. Zampieri, A. Doria, Y. Shoenfeld. Low serum concentrations of 25OH vitamin D inpatients with autoimmune diseases. EULAR, Barcelona (poster)2007H Amital, H Orbach, G Zandman-Goddard, E Kiss, A Doria, Tli Vishne, Z Szekanecz, Y Shoenfeld.Low Serum 25 OH Vitamin D Concentrations in Patients with Systemic Lupus Erythematosus are Associated with Increased Disease Activity. ACR Boston (poster)D-2 papers presented at scientific meetings YearName of Meeting, City, Country1987Shoenfeld Y,Teplizki H, Buskila D, Koike T, Coates ARM, Isenberg D, Horowitz J, Sukenik S. Mycobacterial antigens and autoimmune diseases. ARA Conference 1987, Arthritis Rheum 30:S68:B701988Shoenfeld Y, Buskila D, Abu-Shakra M, Teplizki H, Coates ARM, Krupp M, Sukenik S. Serum monoclonal immunoglobulins from patients with monoclonal gammopathies react with mycobacterial glycolipids and nuclear antigens (DNA, histones, RNP, Sm). XIII. International congress of allergology & clinical immunology. Montreux, Switzerland.p.2501991Amital-Teplizki H, Avinoach I, Kooperman, Blank M, Shoenfeld Y. Binding of monoclonal anti-DNA and anti-TB glycolipids to brain tissue. Third International Congress on Neuroimmunology, Jerusalem, Israel1995Levy Y, Ziporen L, Adler Y, Gilburd B, Amital H, Polak-Charcon S, Cledes J, Youinou P, Shoenfeld Y. Renal involvement in antiphospholipid syndrome-description of six patients and induction of renal injury in SCID mice. Fourth International Conference on SLE, Jerusalem, Israel1998Amital H, Krause I, Levi Y, Blank M, Barak V, Langevitz P, Afek A, Nicoletti F, Kupolovic J, Gilburd B, Meroni PL, Shoenfeld Y. 2nd central European congress of Rheumatology. Warsaw, Poland1999Amital H, Levy Y, Davidson C, Lundberg I, Harju A, Kosach Y, Asherson RA, Shoenfeld Y. Catastrophic antiphospholipid syndrome: Remission following leg amputation in 2 cases. Annual meeting of the Israeli society of Rheumatology , Israel1999Amital H, Levy Y, Rewald E, Bar-Dayan Y, Manthorpe R, Engervall P, Sherer Y, Langevitz P, Shoenfeld Y. Fibrosis regression induced by intravenous gammaglobulin therapy. Annual meeting of the Israeli society allergy and clinical immunology2000Amital H, Reifen R, Blank M, Sklan D, Berkovich Z, Gershwin E, Shoenfeld Y. Linseed oil suppresses the anti-cardiolipin antibodies in experimental antiphospholipid syndrome. Annual meeting of the Israeli society of Rheumatology, Israel2001Amital H. Medical relief missions, the experience of the IDF Medical Corps, Israel2002Amital H, Levy Y, Langevitz P, Rubinow A, Shoenfeld Y. Leg amputation –possible therapeutic role in catastrophic anti-phospholipid syndrome (CAPS)? 10th International Congress on Antiphospholipid Antibodies. Taromina, Italy2002Mandel D, Zimlichman E, Amital H, Wartenfeld R, Benyamini L,Mimouni FB, Kreiss Y. Quality assesment of primary care in primary health clinics. National Forum of Health improvement, Orlando, USA2002Amital H, Gilburd B, Levy A, Shoenfeld Y. Probiotic supplementation with Lactobacillus casei (Actimel) induces a Th1 response in an animal model of the antiphospholipid syndrome. Annual meeting of the Israeli society of Rheumatology, Israel2003Amital H, Gilburd B, Levy A, Shoenfeld Y. Probiotic supplementation with Lactobacillus casei (Actimel) induces a Th1 response in an animal model of the antiphospholipid syndrome. EULAR, Lisbon, Portugal2003Amital H, Aamar S, YH Applabaum, Rubinow A. SAPHO syndrome treated with pamidronate – an open labeled study in 8 patients. European League Against Rheumatism (EULAR) Lisbon, Portugal2003Amital H, Aamar S, YH Applabaum, Rubinow A. SAPHO syndrome treated with pamidronate – an open labeled study in 8 patients. Orlando, USA. American College of Rheumatology, ACR, 2003 (poster). 2003Naparstek Y, Szafer F, Ulmansky R, Heilweil M, Foster M, Mostoslavsky G, Eilat D, Pizov H, Amital H. Treatment With a Laminin-Derived Peptide Suppresses Lupus Nephritis, ACR, Orlando, USA2004Amital H, Amital D, Fostick L, Pollack M, Segev S, Zohar J, Rubinow A. Fibromyalgia in men and the Post-Traumatic Stress Disorder. European League Against Rheumatism (EULAR) Berlin, Germany (oral presentation).2004Amital H, Aries PM, Lane SE on behalf of EURORITS, working party on Education An analysis of training curriculums throughout Europe: Report of European Trainee Survey of the EURORIT (European Rheumatologists in training) European League Against Rheumatism (EULAR) Berlin, Germany (oral presentation). 2004Amital H, Amital D, Fostick L, Pollack M, Segev S, Zohar J, Rubinow A.. What causes fibromyalgia? Comparing the impact of Post-Traumatic Stress Disorder and depression on the development of fibromyalgia in men. San-Antionio, USA. American College of Rheumatology, ACR (oral presentation). 2004Amital H, Barak V, Winkler RE, Rubinow A. Impact of treatment with infliximab on serum cytokine concentration in patients with rheumatoid arthritis (RA). Annual meeting of the Israeli society of Rheumatology, Israel2005Amital H, Fostick L, Amital D, Zilberman A, Zohar J, Rubinow A. Protective aspects of physical activity on male patients with post traumatic stress disorder and fibromyalgia. European League Against Rheumatism (EULAR) Vienna, Austria (poster)2005Amital D, Fostick L, Silberman A, Herskovitz C, Doron Y, Zohar J, Itsekson A, Rubinow A, Amital H. Hormonal PTSD? Aspect of tenderness in patients with the premenstrual syndrome. Annual meeting of the Israeli society of Rheumatology, Israel2006Amital D, Fostick L, Silberman A, Herskovitz C, Doron Y, Zohar J, Itsekson A, Rubinow A, Amital H. Hormonal PTSD? Aspect of tenderness in patients with the premenstrual syndrome. ACR, Washington DC.2006Amital H, Heilweil M, Ulmansky R, Toubi E, Naparstek Y. A Laminin Epitope Vrt101 Serves as a Target in Human Lupus Nephritis. ACR, Washington DC. 2006Amital H, Szekanecz Z, Szücs G, Dankó K, Nagy E, Csépány T, Orbach H, Zandman-Goddard G, Corocher N, Shoenfeld Y. Low serum concentrations of 25 OH Vitamin D in patients with autoimmune diseases. 5th International Congress on Autoimmunity. Sorrento Italy2007H. Amital, M. Heilweil, R. Ulmansky, M. Harlev, E. Toubi, Y. Naparstek . A LAMININ EPITOPE VRT101 SERVES AS AN TARGET IN HUMAN LUPUS NEPHRITIS. EULAR, Barcelona2007Z. Dovrish, T. Vishne2, D. Amital, A. Rubinow, H. Amital. FIBROMYALGIA AMONG MAJOR DEPRESSION DISORDER FEMALES COMPARED TO MALESEULAR, Barcelona 2007H. Amital, H. Orbach, G. Zandman-Godard, Z. Szekanecz, G. Szuc, K. Danko, T. Csepany, E. Kiss, S. Zampieri, A. Doria, Y. Shoenfeld. Low serum concentrations of 25OH vitamin D inpatients with autoimmune diseases. EULAR, Barcelona2007H Amital, H Orbach, G Zandman-Goddard, E Kiss, A Doria, Tli Vishne, Z Szekanecz, Y Shoenfeld.Low Serum 25 OH Vitamin D Concentrations in Patients with Systemic Lupus Erythematosus are Aassociated with Increased Disease Activity. ACR Boston20072008200820082008200820082008200920092010 2011M Heilweil-Harel, H Amital, R Ulmansky, M Harlev, E Toubi, A Hershko, Y Naparstek. Antibodies against the VRT101 Laminin Epitope Correlate with Human SLE Disease Activity and Can be Removed by Extracorporeal Immunoadsorption. ACR BostonEFFICACY AND SAFETY OF RITUXIMAB IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS??? ?R.V. Denisova1, E.I. Alexeyeva1, T.M. Bzarova1, H. Amital2, S.I. Valiyeva1, S.S. Akulova1, K.B. Isayeva1, A.M. Chomakhidze1, A.O. Lisitsyn1, E.Y. Gudkova1??? EULAR, Paris, ?2008HEPATOTOXICITY RATES DO NOT DIFFER IN PATIENTS WITH RHEUMATOID AND PSORIATIC ARTHRITIS TREATED WITH METHOTREXATE??Y. Arnson1, G. Hodik2, V. Shalev2, H. Amital1???EULAR, Paris, ?2008Bioinformatic and Biological Analysis of the Anti-inflammatory Target A3 Adenosine Receptor in Psoriasis, Crohn’s Disease and Rheumatoid Arthritis.Sara Bar Yehuda1, Avivt Ochaion1, Shira Cohen1, Faina Barer1, Renana Patoka1, Howard Amital2, Tatiana Reitblat3, Alexander Reitblat3, Josef Ophir4, Itzhak Konfino4, Yehuda Chowers5, Shomron Ben Horin5, Luis Del Valle6, Georginia Perez-Liz6, Pnina Fishman1.ACR, San Francisco, 2008 Early treatment with biologics, lessons from the Best and the Commit studies. Polish Congress of Rheumatology, Warsaw, 2008, (Invited speaker)ANTIBODIES AGAINST THE VRT101 LAMININ EPITOPE CORRELATE WITH HUMAN SLE DISEASE ACTIVITY AND CAN BE REMOVED BY EXTRACORPOREAL IMMUNOADSORPTIONY. Naparstek, M. Heilweil-Harel, H. Amital, A. Scheiman Elazari1, S. Aamar1, R. Ulmansky1, M.Harlev3, E. Toubi4, A. Hershko1AUTOIMMUNITY CONGRESS, Porto, 2008HEPATOTOXICITY RATES DO NOT DIFFER IN PATIENTS WITH RHEUMATOID AND PSORIATICARTHRITIS TREATED WITH METHOTREXATEH. Amital1, Y. Arnson1, G. Hodik2, V. Shalev3AUTOIMMUNITY CONGRESS, Porto, 2008, Invited speakerEXPANSION OF ANTIPHOSPHOLIPID AUTOANTIBODY SCREEN IN RHEUMATOID ARTHRITISY. Sherer, H. Amital, D. Shepshelovich, O. Barzilai, M. Ram, N. Agmon-Levin, M. Blank, B. Larida,Y. ShoenfeldAUTOIMMUNITY CONGRESS, Porto, 2008EFFICACY AND SAFETY OF RITUXIMAB RETREATMENT IN REFRACTORY JUVENILE IDIOPATHIC ARTHRITISE.I. Alexeeva, T.M. Bzarova, H. Amital, E.L. Semikina, S.I. Valieva, S.S. Akulova, E.A. Kopyilcova, K.B. Isayeva, A.M. Chomahidze, A.O. Lisitsin, R.V. Denisova, E.U. Gudkova Copenhagen, EULAR 2009 Vitamin D: An Instrumental Factor in the Anti-Phospholipids Syndrome - Inhibiting Tissue Factor Expression.Nancy Agmon-Levin, Maya Glazer, Howard Amital, Gisele Zandman-Goddard, Hedi C. Orbach, Shlomo Berliner, Pierluigi Meroni, Angela Tincani, Andrea Doria, Ricard Cervera, Wolfgang Miesbach, Ljudmila Stoyanovich, Vivian Barak, Bat-Sheva Porat katz, Miri Blank and Yehuda ShoenfeldPhiladelphia ACR, 2009 The A3 Adenosine Receptor as a Biological Predictive Marker in Rheumatoid Arthritis: Lessons From Phase II Clinical Studies MH Silverman, S. Aamar, T. Reitblat, D. Markovitz, H. Amital, Z. Harpaz, S. Fishman, M. Farbstein, S. Bar Yehuda, A. Ochaion, S. Cohen, F. Barer, R. Patoka, G. Zozulya and P. Fishman P.Philadelphia ACR, 2009 Serum Concentrations of 25-OH Vitamin D in SLE Patients Are Inversely Related to Disease Activity- Is It Time to Routinely Supplement SLE Patients with Vitamin D? Howard Amital, Zoltá Szekanecz, Gabriella Szücs, Katalin Dankó, Endre Nagy, Tünde Csépány, Emese Kiss, Andrea Doria, Nadia Corocher, Nancy Agmon-Levin, Hedi C. Orbach, Gisele Z. Goddard and Yehuda Shoenfeld,Philadelphia ACR, 2009 HMG-CoA Reductase Inhibitors (statins) Provides Primary Prevention for Rheumatoid ArthritisHoward Amital, Gabriel Chodick, Yoav Shalem and Varda Shalev. (Oral Presentation)Philadelphia ACR, 2009The development of pain syndrome among patients with Breast cancer Michal Shrier, Daniella Amital, Bella Nisenbaum, Alan Rubinow, Howard AmitalEilat 2009, Israeli Psychiatric association (Oral presentation) Efficacy and safety of RITUXIMAB in patienst with juvenile idiopathic arthritisE.I. Alexeeva, T.M. Bzarova, H. Amital, E.L. Semikina, S.I. Valieva, S.S. Akulova, E.A. Kopyilcova, K.B. Isayeva, A.M. Chomahidze, A.O. Lisitsin, R.V. Denisova, E.U. Gudkova International symposium on the central role of B cells in Autoimmune Disease Technion, Hafia, 2009 (Oral presentation)Association of Fibromyalgia characteristics in patients with non-metastatic breast cancer and the protective role of resilience. Arnson Y, Schrier M, Amital D, Rubinow A, Nissenabaum B, Amital HRome, EULAR 2010 Israeli Association of Primary care- a guest head of session and organizer of Rheumatology session (2.6.10, Jerusalem)======================================Oranizor and coordinator of the orthopedic surgery and rheumatology joint congress for family physicians, Tel-Aviv (23.3.2011) with Prof. Nahum HalperinHoward Amital, Vered Alush-Biber, Nancy Agmon Levine, Arnon Cohen. Coexistence of Rheumatoid Arthritis and Chronic Obstructive Pulmonary Disease: a case–control study, Israeli society of rheumatology – oral presentation Howard Amital, Vered Alush-Biber, Nancy Agmon Levine, Arnon Cohen.Coexistence of Rheumatoid Arthritis and Chronic Obstructive Pulmonary Disease: a case–control study, London 2011, EULARHoward. Amital, Nancy Agmon-Levin, Mario Sánchez-Casta?ón, Marco Matucci-Cerinic, Gabriella Szücs, Yoav Arnson, Yinon Shapira, Zoltan Szekanecz, Yehuda Shoenfeld Serum. 25-OH Vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis. London 2011, EULAR8e. academic and professional awards(Prizes, fellowships, grants, scholarships, etc)Year (Duration)Name of Institution, city, country, Occasion, Title, Sum FORMTEXT 1. FORMTEXT 1986- The Gulton Fund, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva FORMTEXT 400$. P.I. FORMTEXT Immunoglobulin secretion in mononuclear cells induced by various mitogens. FORMTEXT 2.1986- The Gulton Fund, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, 400$. P.I FORMTEXT A multidimensional autoantibody analysis specifying SLE patients with neuropsychiatric symptomatology. FORMTEXT 3.1989- The Israel Institute for Psychobiology Charles E. Smith Family Foundation - 10,000$. P.I FORMTEXT Autoimmune Aspects of Schizophrenia. FORMTEXT 5.1989- Mifal Hapais, P. Sappir Foundation. FORMTEXT 15,000 ? . P.I FORMTEXT Human-Human Hybridoma Applications in Various Rheumatic Diseases. FORMTEXT 6.1989-Levi Eshkol Foundation, Ministry of science and development. 15,000$. P.I FORMTEXT The frequency of a common anti-DNA antibody idiotype (16/6) in different populations of patients with systemic lupus erythematosus. Publications due to this grant. P.I7. 1996 - Research grant from the ministry of health, No 3423. 15,000 ? I. Induction of Libman Sacks endocarditis by passive perfusion of cardiolipin in isolated rats heart. CO-P.I8. 2000-Israel Defense Forces Medical Corps. 50,000 ?. Comparison of tilt test training to ADH administration in young soldiers with recurrent syncope. CO-PI9. 2002 - Danone Institute. 45,000 ?. P.I Probiotic supplementation in autoimmunity. PI10. 2004 - Shering-Plough, 7,500$. Impact of treatment with infliximab on serum cytokine concentration in patients with rheumatoid arthritis (RA). PI11. 2008 – MSD – investigator initiative, 85,000$. A randomized double-blinded study comparing adding etoricoxib versus placebo to female patients with fibromyalgia-analysis of organic and psychiatric measures. PI12. 2008, Sherutai bruit clalit. 20,000 NIS. Recurrent admissions due to chronic obstructive pulmonary diseases, CO-PIAWARDS:1. 1986- Bornstein's Prize for Neuroscience,. Neurology Department, Belinson Medical Center, Petach-Tikva, Israel. "Low serum anti-mycobacterial Glycolipid antibodies titer in the sera of patients with systemic lupus erythematosus as an indicator of central nervous system involvement".2. 2005 – prize for the outstanding clinical study. Annual meeting of the Israeli society of Rheumatology, Israel. Hormonal PTSD? Aspects of tenderness in patients with the premenstrual syndrome.3. 2008, Research day, Meir Medical Center, Autoimmune aspects of vitamin D. f. membership in professional societiesYearSociety (Country)200020042006Israeli society of Rheumatology (member of the society committee 2005-2008)Member of the American College of RheumatologyIsraeli society of Internal MedicineName: (First)(Last)Academic Degreeg. doctoral students supervised by candidatePeriod (years) 2006-2007Period (years) 2007-20082009-2010Basic Science residencies20072007200920092010Nashat OmarMPH 2010 Avi Leader (Name of student)?Hadassah Medical Center, Hebrew University Michal Shrayer (Name of student) The development of fibromyalgia syndrome among patients with Breast cancer, and the assessment of it's relation to Type D personality.Hadassah Medical Center, Hebrew University Vered Bibar (Name of student)Comorbidity of COPD and rheumatoid arthritisBen Gurion University, Beer-ShevaDevelopment of depression and pain in patients following acute Myocardial infarction – Dr. Irena Gidenson The occurrence of psychiatric illnesses in patients with atopic dermatitis, contact dermatitis and other dermatoses - Dr. Baruch PanrovskyAssociation of vitamin D serum concentrations to disease severity in schizophrenia and depression – Dr. Katya GordernAssociation of vitamin D serum concentrations to survival among patients hospitalized in intensive care units – Dr. Irena GringhauzSerum cytokine concentrations in patients with major depression and schizophrenia – Dr. Ayala YogevMagister Yoav Shalem, MPH 2009 HMG-CoA reductase inhibitors (statins) and the risk of Rheumatoid Arthritis Tel-Aviv UniversityRates of malignancies in systemic sclerosis Appointments at other Universities: Lecturer Hebrew UniversityExcellent teacher 2003 elected by fourth year medical studentsIn process – Professor of Medicine Ben-Gurion University Sackler Faculty of Medicine, Tel Aviv University: FORMTEXT 1994 – Tutor fourth year medical student tutor, (Internal Medicine rotation) Sackler Faculty of Medicine, Tel-Aviv University.1995- Tutor in charge, fourth year medical student tutor (Internal Medicine rotation) Sackler Faculty of Medicine, Tel-Aviv University.1996- Tutor in charge, fourth year medical student tutor – American Program (Physical examination rotation) Sackler Faculty of Medicine, Tel-Aviv University.1998-9 - Tutor fourth year medical students, (Physical examination & Internal Medicine rotation) Sackler Faculty of Medicine, Tel-Aviv University.Excellent tacher 1999 - elected by fourth year medical students. Senior lecturer Tel-Aviv University, 2007Head of the assessment committee, Faculty of Medicine, 2007.Member of the clinical teaching committee, Sackler Faculty of Medicine, Tel-Aviv University (2008) (??? ???? ????? ???????? ???????)Head of subcommittee of the Scientific Consulate of the Israeli Medical Association (2009)Head of the Israeli Inter Faculty assessment committee 2009. (??"? ???? ??? ?????? ????? ???? ????????)6. Other activities: Administrative secretary of the European Fellows of Rheumatology - EURORITS/ EULAR 2003/2004Member of the Helsinki Borad (Ethical Committee) Meir Medical Center, 2006-Member of the Helsinki Board Medical Corps, IDF 20107. Principle investigator – Canfite-2007A randomized, double-blind, parallel group, international study to evaluate the safety and efficacy of ocrelizumab in combination with methotrexate (MTX) compared to MTX alone in methotrexate- na?ve patients with active rheumatoid arthritis Roche -2008.A randomized, double-blind, parallel group, international study to evaluate the safety and efficacy of ocrelizumab in combination with methotrexate (MTX) compared to MTX alone in patients with rheumatoid arthritis following failure of anti-TNF therapy-2008.Outcomes After Switching From One Anti-Tumor Necrosis Factor Alpha Agent to a Second Anti-Tumor Necrosis Factor alpha Agent in Patients with Rheumatoid Arthritis. Shering Plough – 2008.Infliximab Plus Methotrexate Significantly Improves Rates of Remission for Methotrexate Na?ve Psoriatic Arthritis (PsA) Patients Compared to Methotrexate Alone: The RESPOND? Trial, Centacor, 2008Randomized placebo-controlled study to evaluate the safety and efficacy of adding tocilizumab (TCZ) to methotrexate (MTX) versus switching to TCZ (placebo-controlled), with possible addition of other disease-modifying anti-rheumatic drugs (DMARDs), in patients with active rheumatoid arthritis who have inadequately responded to prior MTX treatment (F. Hoffman-La Roche ACT-RAY MA21488A)-2009A Randomized, Double-Blind Comparison of Duloxetine 30 mg QD and Placebo in Adult Patients With Fibromyalgia (Eli Lilly and Company) 2009A multi-center, randomized, double-blind, parallel group study of the safety, disease remission and prevention of structural joint damage during treatment with tocilizumab (TCZ), as a monotherapy and in combination with methotrexate (MTX), versus methotrexate in patients with early, moderate to severe rheumatoid arthritis. F. Hoffmann-La Roche LTD (Roche) 2009Member of Editorial boardsAutoimmunity reviewsHarefuahREVIEWERAutoimmunity reviewsAnnals of the Rheumatic Diseases Arthritis & RheumatismArthritis Care & ResearchSeminars of Arthritis & RheumatismRheumatologyJournal of RheumatologyJournal of HepatologyEuropean Respiratory JournalClinical Experimental RheumatologyJournal of Psychosomatic Research Rheumatology InternationalClinical RheumatologyThoraxScandinavian Journal Of RheumatologyInternational Journal of Clinical RheumatologyInternational Journal of DermatologyEnvironmental Health PerspectivesIMAJHarefuahClinical biochemsitryB.1. Original ArticlesTeplizki H, Buskila D, Argov S, Isenberg DA, Coates ARM, Sukenik S, Horowitz J and Shoenfeld Y. Low serum anti-mycobacterial glycolipid antibodies' titer in the sera of patients with systemic lupus erythematosus as an indicator of central nervous involvement. J Rheumatol 14:507-514,1987.Teplizki H, Buskila D, Alkan M, Coates ARM, Baumgarten A and Shoenfeld Y. Elisa measurment of antibody titer to purified protein derivative and mycobacteria derived phosphoglycolipids: tool for diagnosing active pulmonary tuberculosis. Isr J Med Sci 23:1121-1124,1987.Shoenfeld Y, Teplizki H, Buskila D, Luedemann J and Gross W. Immunoglobulin secretion in mononuclear cells induced by various mitogens. Int J Immunopharmacol 4:347-352,1988.Shoenfeld Y, Livne A, Blank M, Argov S, Krup M, Fleishmakher E, Sukenik S and. Teplizki H. A human monoclonal anti-DNA antibody derived from a patient with polymyositis having a common lupus 16/6 idiotype. Immunol Lett 19:77-84,1988.Hundert I, Bakimer R, Teplizki H, Slor H, Yassur Y, Palestine A, Nussenblatt RB and Shoenfeld Y. Antinuclear autoantibodies in uveitis. Clin Exp Rheumatol 7:237-241,1989.Buskila D, Abu-Shakra M, Amital-Teplizki H, Coates ARM, Krupp M, Sukenik S and Shoenfeld Y. Serum monoclonal immunoglobulins from patients with multiple myeloma react with mycobacterial glycolipids and nuclear antigens (DNA, histones, RNP, Sm). Clin Exp Immunol 76:378-383,1989.Amital-Teplizki H, Avinoach I, Coates ARM, Kooperman O, Blank M and Shoenfeld Y. Binding of monoclonal anti-DNA and anti-TB glycolipids to brain tissue. Autoimmunity 4:277-287,1989.Avinoach I, Amital-Teplizki H, Kooperman O, Isenberg DA, Sukenik S, Coates ARM and Shoenfeld Y. Characteristics of anti-neural antibodies in SLE patients with and without mycobacterial cross - reacting antigens. Isr J Med Sci 26:367-373,1990.Swissa M, Amital-Teplizki H, Cohen Y and Shoenfeld Y. Autoantibodies in neoplasia - an unresolved enigma. Cancer 65:2554-2558,1990.Bakimer R, Krause I, Abu-Shakra M, Amital-Teplizki H, Isenberg DA, Alarcon-Segovia D. Villarreal GM, Shoenfeld Y. The frequency of a common anti-DNA idiotype (16/6) in different populations of patients with SLE. J Rheumatol 18:1035-1037,1991.Amital-Teplizki H, Bearman JE, Mielke PW, Fleishmakher E, Isenberg DA, Sukenik S, Avinoach I and Shoenfeld Y. A multidimensional autoantibody analysis specifying SLE patients with neuropsychiatric symptomatology. Isr J Med Sci 28.422-427,1992.Amital-Teplizki H, Klemperer I, Blank M, Nussenblatt RB, Palestine A, Yassur Y and Shoenfeld Y. Analysis of autoantibodies among patients with primary and secondary uveitis. Int Arch of Immunol Allergy 99:34-36,1992.Amital-Teplizki H, Sela B, Shoenfeld Y. Autoantibodies to brain lipids among patients with schizophrenia: A puzzle. Immunol Res 11:66-73,1992.Green L, Vinker S, Amital H, A Tanay, Bar-Dayan Y, Levi Y, Shoenfeld Y. Pseudotumor cerebri in SLE. Seminars Arthritis Rheum 25:103-106,1995. Yanai-Landau H, Amital H, Bar-Dayan Y, Levy Y, Gur H, Lin HC, Alosachie IJ, Peter JB, Shoenfeld Y. Autoimmune aspects of primary pulmonary hypertension. Pathobiology 63:71-75,1995. Bar-Dayan Y, Amital H, Levi Y, Shoenfeld Y. Low dose aspirin in patients with ischemic heart disease may precipitate secondary myocardial infarction. Isr J Med Sci, 32: 288-291,1996. Levy Y, Ziporen L, Gilburd B, George J, Polak-Charcon S, Amital H, Cledes J, Youinou P, Shoenfeld Y. Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID mice. Hum Antibodies Hybridomas 7:91-96,1996 .Bar-Dayan Y, Levy Y, Amital H, Shoenfeld Y. Aspirin for prevention of myocardial infarction. A double-edged sword. Ann Med Interne (Paris);148:430-433,1997. Bar-Dayan Y, Blank M, Amital H, Afek A, Polak-Charcon S, Shoenfeld Y. Short term effect of high dose insulin on thymic morphology of ICR mice. Diabetes Research 32:27-35,1997. Carmel A, Amital H, Shemer S, Sahar A. Clinical characteristics of those who leave the emergency room against advice . Harefuah, 134:445-449,1998. (Hebrew)Portugese S, Amital H, Tenenbaum A, Bar-Dayan Y, Levy Y, Afek A, Shemesh J, Shoenfeld Y. Clinical characteristics of ruptured chordae tendineae in hospitalized patients: primary tear versus infective endocarditis. Clin Cardiol 21:813-816,1998. Amital H, Levi Y, Blank M, Barak V, Langevitz P, Afek A, Nicoletti F, Kopolovic J, Gilburd B, Meroni PL, Shoenfeld Y. Immunomodulation of murine experimental SLE-like disease by interferon-gamma. Lupus, 7:445-454,1998. Reifen R, Amital H, Blank M, Sklan D, Berkovich Z, Gershwin E, Shoenfeld Y. Linseed oil suppresses the anti-cardiolipin antibodies in experimental antiphospholipid syndrome. J Autoimmun, 15:381-385,2000. Blank M, Levy Y, Amital H, Shoenfeld Y, Pines M, Genina O. The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin mice. Arthritis Rheum 46:1689-90,2002. Amital H, Rewald E, Levy Y, Bar-Dayan Y, Manthorpe R, Engervall P, Sherer Y, Langevitz P, Shoenfeld Y. Fibrosis regression induced by intravenous gammaglobulin treatment. Ann Rheum Dis 62:175-7,2003. Levy Y, Uziel Y, Goddard-Zandman G, Amital H , Sherer Y, Langevitz P, Goldman B, Shoenfeld Y. Intravenous immunoglobulins (IVIg) in peripheral neuropathy associated with vasculitis. Ann Rheum Dis 62:1221-3,2003.Amital H, Alkan ML, Adler J, Kriess I, Levi Y. Israeli Defense Forces Medical Corps humanitarian mission for Kosovo's refugees. Prehospital Disaster Med 18:301-5,2003.Levy Y, Amital H, Langevitz P, Nacci F, Righi A, Conforti L, Generini S, Matucci Cerinic M, Shoenfeld Y. Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study. Arthritis Rheum 50:1005-7,2004.Amital H, Applbaum YH, Aamar S, Daniel N, Rubinow A. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology (Oxford).43:658-61,2004.Mandel D, Amital H, Zimlichman E, Wartenfeld R, Benyamini L, Shochat T, Mimouni FB, Kreiss Y. Quality assessment program in primary care clinics: a tool for quality improvement. Int J Qual Health Care 16:175-80,2004. Amital H, Glikson M, Burstein M, Afek A, Sinnreich R, Weiss Y, Israeli V. Clinical characteristics of unexpected death among young enlisted military personnel: results of a three-decade retrospective surveillance. Chest 126:528-33,2004.Aries PM, Amital H, Lane SE. EURORITS: Rheumatology education in Europe under scrutiny. Preliminary results of a European survey.Z Rheumatol 63:428-9,2004. (German)Amital D, Fostick L, Sasson,Y, Kindler S, Amital,H, Zohar,J. Anxiogenic effects of Sumatriptan in panic disorder: a double-blind, placebo-controlled study. Eur Neuropsychopharmacol 15:279-82,2005.Levy Y, Uziel Y, Zandman G, Rotman P, Amital H, Sherer Y, Langevitz P, Goldman B, Shoenfeld Y. Response of vasculitic peripheral neuropathy to intravenous immunoglobulin. Ann N Y Acad Sci.;1051:779-86,2005.Amital H, Rubinow A, Naparstek Y.Alveolar hemorrhage in cryoglobulinemia--an indicator of poor prognosis. Clin Exp Rheumatol 23:616-20,2005. Amital H, Heilweil M, Ulmansky R, Szafer F, Bar-Tana R, Morel L, Foster MH, Mostoslavsky G, Eilat D, Pizov G, Naparstek Y. Treatment with a laminin-derived peptide suppresses lupus nephritis. J Immunol. 175:5516-23,2005.Amital D, Fostick L, Polliack ML, Segev S, Zohar J, Rubinow A, Amital H.Posttraumatic stress disorder, tenderness, and fibromyalgia syndrome: are they different entities? J Psychosom Res 61:663-9, 2006.38. Ochaion A, Bar-Yehuda S, Cohn S, Del Valle L, Perez-Liz G, Madi L, Barer F, Farbstein M, Fishman-Furman S, Reitblat T, Reitblat A, Amital H, Levi Y, Molad Y, Mader R, Tishler M, Langevitz P, Zabutti A, Fishman P.Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression.Arthritis Res Ther 8:R169-181, 2006.39. Golan I, Nedvetzki S, Golan I, Eshkar-Sebban L, Levartovsky D, Elkayam O, Caspi D, Aamar S, Amital H, Rubinow A, Naor D. Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody.J Autoimmun 28:99-113, 2007.40. Eshkar Sebban L, Ronen D, Levartovsky D, Elkayam O, Caspi D, Aamar S, Amital H, Rubinow A, Golan I, Naor D, Zick Y, Golan I. The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation.J Immunol 1791225-35, 2007.41. Arnson Y, Amital D, Fostick L, Silberman A, Polliack ML, Zohar J, Rubinow A, Amital H. Physical activity protects male patients with post-traumatic stress disorder from developing severe fibromyalgia. Clin Exp Rheumatol 25:529-33, 200742. Amital H, Heilweil-Harel M, Ulmansky R, Harlev M, Toubi E, Hershko A, Naparstek Y. Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption.Rheumatology (Oxford). 46:1433-7, 2007. (IF-4.236, Category-Rheumatology 7/22)43. Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, Danko K, Nagy E, Csepany T, Carvalho JF, Doria A, Shoenfeld Y. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci; 1109:385-400, 2007. (IF-2.670, Category-Multidisplinary Sciences 5/42)44. Carvalho JF, Blank M, Kiss E, Tarr T, Amital H, Shoenfeld Y.Anti-vitamin D, vitamin D in SLE: preliminary results. Ann N Y Acad Sci. 1109:550-7, 2007. (IF-2.670, Category-Multidisplinary Sciences 5/42)45. Gurevitz O, Barsheshet A, Bar-Lev D, Zimlichman E, Rosenfeld GF, Benderly M, Luria D, Amital H, Kreiss Y, Eldar M, Glikson M.Tilt training: does it have a role in preventing vasovagal syncope?Pace 30:1499-505, 2007. (IF-1.590, Category-Cardiology 56/95)46. Amital H, Barak V, Winkler RE, Rubinow A.Impact of treatment with infliximab on serum cytokine profile of patients with rheumatoid and psoriatic arthritis.Ann N Y Acad Sci. 1110:649-60, 2007. (IF-2.670, Category-Multidisplinary Sciences 5/42)47.Amital H, Gilburd B, Shoenfeld Y.Probiotic supplementation with Lactobacillus casei (Actimel) induces a Th1 response in an animal model of antiphospholipid syndrome.Ann N Y Acad Sci. 1110:661-9, 2007. (IF-2.670, Category-Multidisplinary Sciences 5/42)48. Vishne T, Fostick L, Silberman A, Kupchick M, Rubinow A, Amital H, Amital D.Fibromyalgia among major depression disorder females compared to males.Rheumatol Int. 2008 28:831-6. (IF-1.493, Category-Rheumatology 19/22)49. Ochaion A, Bar-Yehuda S, Cohen S, Amital H, Jacobson KA, Joshi BV, Gao ZG, Barer F, Patoka R, Del Valle L, Perez-Liz G, Fishman P. The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats. Biochem Pharmacol. 2008 76:482-94. (IF-4.254, Category-Pharmacology and Pharmacy 34/236)50. Ochaion A, Bar-Yehuda S, Cohen S, Barer F, Patoka R, Amital H, Reitblat T, Reitblat A, Ophir J, Konfino I, Chowers Y, Ben-Horin S, Fishman P. The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease. Cell Immunol. 2009;258:115-22. (IF-2.698, Category-Immunology 66/128)51. Amital H, Arnson Y, Chodick G, Shalev V. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate. Rheumatology (Oxford). 2009 48:1107-10. (IF-4.236, Category-Rheumatology 7/22)52. Arnson Y, Amital H, Guiducci S, Matucci-Cerinic M, Valentini G, Barzilai O, Maya R, Shoenfeld Y. The role of infections in the immunopathogensis of systemic sclerosis—evidence from serological studies. Ann N Y Acad Sci. 2009 1173:627-32 (The first two authors have equally contributed to this paper). (IF-2.670, Category-Multidisplinary Sciences 5/42)53. Plot L, Amital H, Barzilai O, Ram M, Nicola B, Shoenfeld Y. Infections may have a protective role in the etiopathogenesis of celiac disease. Ann N Y Acad Sci. 2009;1173:670-4. (The first two authors have equally contributed to this paper). (IF-2.670, Category-Multidisplinary Sciences 5/42)54. Leader A, Amital D, Rubinow A, Amital H. An open-label study adding creatine monohydrate to ongoing medical regimens in patients with the fibromyalgia syndrome. Ann N Y Acad Sci. 2009; 1173:829-36. (IF-2.670, Category-Multidisplinary Sciences 5/42)55. Amital D, Herskovitz C, Fostick L, Silberman A, Doron Y, Zohar J, Itsekson A, Zolti M, Rubinow A, Amital H. The Premenstrual Syndrome and Fibromyalgia-Similarities and Common Features.Clin Rev Allergy Immunol. 2010;38:107-15. (IF-2.597, Category-Immunology 71/128)56. Meron MK, Amital H, Shepshelovich D, Barzilai O, Ram M, Anaya JM, Gerli R, Nicola B, Shoenfeld Y. Infectious Aspects and the Etiopathogenesis of Rheumatoid Arthritis. Clin Rev Allergy Immunol. 2010 38:287-91 (The first two authors have equally contributed to this paper). (IF-2.597, Category-Immunology 71/128)57. Amital H, Szekanecz Z, Szücs G, Dankó K, Nagy E, Csépány T, Kiss E, Rovensky J, Tuchynova A, Kozakova D, Doria A, Corocher N, Agmon-Levin N, Barak V, Orbach H, Zandman-Goddard G, Shoenfeld Y. Serum concentrations of 25-OH Vitamin D in SLE patients are inversely related to disease activity- is it time to routinely supplement SLE patients with vitamin D? Ann Rheum Dis. 2010 69:1155-7 (IF-8.111, Category-Rheumatology 1/22) 58. Chodick G, Amital H, Shalem Y, Kokia E, Heymann AD, Porath A, Shalev S. Persistence with statins and onset of rheumatoid arthritis: A population-based cohort study. (The first two authors have equally contributed to this paper).Plos Medicine 2010 Sep 7;7(9):e1000336 (IF-13.02, Category- Medicine, General & Internal- 6/132) 59. Ponarovsky B, Amital D, Lazarov A, Kotler M, Amital H. Anxiety and depression in patients with allergic and non-allergic cutaneous disorders.Int J Dermatol, (IF-1.177, Category- Dermatology -34/48) (in press)60. Agmon-Levin N, Blank M, Zandman-Goddard G, Orbach H, Meroni PL, Tincani A, Doria A, Cervera R, Miesbach W, Stojanovich L, Barak V,.Porat-Katz BS, Amital H, Shoenfeld Y.Vitamin-D: an instrumental factor in the anti-phospholipids syndrome – inhibiting tissue factor expression. Ann Rheum Dis. 2011 70:145-50 (IF-8.111, Category-Rheumatology 1/22) ============================================================== 61. Orbach H, Zandman-Goddard G, Boaz M, Agmon-Levin N, Amital H, Szekanecz Z, Szucs G, Rovensky J, Kiss E, Doria A, Ghirardello A, Gomez-Arbesu J, Stojanovich L, Ingegnoli F, Meroni PL, Rozman B, Blank M, Shoenfeld Y. Prolactin and Autoimmunity : Hyperprolactinemia Correlates with Serositis and Anemia in SLE Patients.Clin Rev Allergy Immunol. 2011 (epub) . (IF-2.597, Category-Immunology 71/128)62. Zandman-Goddard G, Orbach H, Agmon-Levin N, Boaz M, Amital H, Szekanecz Z, Szucs G, Rovensky J, Kiss E, Corocher N, Doria A, Stojanovich L, Ingegnoli F, Meroni PL, Rozman B, Gomez-Arbesu J, Blank M, Shoenfeld Y. Hyperferritinemia is Associated with Serologic Antiphospholipid Syndrome in SLE Patients.Clin Rev Allergy Immunol. 2011 (epub) . (IF-2.597, Category-Immunology 71/128)63. Arnson Y, Amital H, Agmon-Levin N, Alon D, Sánchez-Casta?ón M,López-Hoyos M, Matucci-Cerinic M, Szücs G, Shapira Y, Szekanecz Z, Shoenfeld Y. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: A retrospective cohort study and review ofthe literature. Autoimmun Rev. 2011 (epub) (The first two authors have equally contributed to this paper). (IF-6.368, Category-Immunology 14/128)64. Schrier M, Amital D, Arnson Y, Rubinow A, Altaman A, Nissenabaum B, Amital H.Association of fibromyalgia characteristics in patients with non-metastatic breast cancer and the protective role of resilience.Rheumatol Int. 2012 32:3017-23. Epub 2011 Sep 8.65. Zimlichman E, Shinar Z, Rozenblum R, Levkovich S, Skiano S, Szyper-Kravitz M, Altman A, Amital H, Shoenfeld Y.Using continuous motion monitoring technology to determine patient's risk for development of pressure ulcers.J Patient Saf. 2011 7:181-4. doi: 10.1097/PTS.0b013e318230e6ef66. Arnson Y, Gringauz I, Itzhaky D, Amital HVitamin D deficiency is associated with poor outcomes and increased mortality in severely ill patients.QJM. 2012, 105:633-9. doi: 10.1093/qjmed/hcs014. Epub 2012 Feb 1267. Dougados M, Kissel K, Sheeran T, Tak PP, Conaghan PG, Mola EM, Schett G, Amital H, Navarro-Sarabia F, Hou A, Bernasconi C, Huizinga T.Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY).Ann Rheum Dis. 2012 Jul 7. [Epub ahead of print]68. Zandman-Goddard G, Amital H, Shamrayevsky N, Raz R, Shalev V, Chodick G.Rates of adherence and persistence with allopurinol therapy among gout patients in Israel (Rheumatology, in press)?B 2. Case Reports1. Amital H, Schiby G, Rosenmann Y, Shoenfeld Y. Clinical problem solving -when assumptions are insufficient. Harefuah 127:564-567,1994. (Hebrew)2.Amital H, Shoenfeld Y. Thromboembolic events of heparin induced thrombocytopenia. Harefuah 126:448-450,1994. (Hebrew)3.Horoshowski D, H Amital, M Katz, Y Shoenfeld. Pseudotumor cerebri in SLE. Clin Rheumatol. 14:708-710,1995. 4. Amitai M, Apter S, Heiman Z, Amital H. Imaging of collateral venous systems in portal hypertension. Harefuah 129:283-285,1995. (Hebrew)5. Amitai M, Amital H. Perihilar and mediastinal lymphadenopathy in a young man with fever. Harefuah 130:56-57,1996. (Hebrew)6.Amitai M, Morag B, Onca N, Amital H. Sigmoidal-vesicualr fistula. Harefuah 130:135-134,1996. (Hebrew)7.Amital H, Afek A, Schnur LF. Protracted fever, splenomegaly, and pancytopenia in a 19 year-old man. Harefuah 130:135-137,1996. (Hebrew)8. Amitai M, Yonash M, Amital H. Imaging Corner 4. Acute gastric dilatation in a diabetic patient. Harefuah, 130:292-293,1996. (Hebrew)9. Amitai M, Kaminski N, Simanski D, Sachs N, Amital H. Bronchogenic cyst.Harefuah 16:132:308-309,1997. (Hebrew)10. Levy Y, George Y, Ziporen L, Cledes J, Amital H, Bar-Dayan Y, Afek A, Youinou P, Shoenfeld Y. Massive proteinuria as a main massive manifestation of primary antiphospholipid syndrome.Pathobiology, 66:49-52,1998. 11. Amital H, Langevitz P, Levy Y, Afek A, Goldberg I, Pras M, Livneh A, Shoenfeld Y. Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease. Clin Exp Rheumatol, 17:99-102,1999. 12. Amital H, Levy Y, Shoenfeld Y. Use of intravenous Immunoglobulins in Livedo vasculitis. Clin Exp Rheumatol 18:404-406,2000.13. Leibovitz Y, Amital H, Levy Y, Langevitz P, Shoenfeld Y. Isotretinoin induced Adult onset Still’s disease. Clin Exp Rheumatol 18:616-618,2000.14. Bar Meir E, Amital H, Levi Y, Kneler R, Bar-Dayan Y, Shoenfeld Y. Mycoplasma pneumoniae induced thrombotic thrombocytopenic purpura Acta Hematologica Acta Haematol 103:112-115,2000.15. Amital H, Levy Y, Davidson C, Lundberg I, Harju A, Kosach Y, Asherson RA, Shoenfeld Y. Catastrophic antiphospholipid syndrome: Remission following leg amputation in 2 cases. Semin Arthritis Rheum. 31:127-132,2001. 16. Heyman SN, Marmor S, Ben-Abraham R, Shani Y, Heled Y, Shapira I, Lifschitz-Mercer B, Amital H. Multi-organ failure in a young soldier, a clinical –pathological meeting. Harefuah. 141:204-209,2002. (Hebrew)17. Neudorf-Grauss R, Weiss Y, Hiss J, Amital H. Aortic dissection in a young woman with Turner's syndrome. Eur J Intern Med.13:463-464,2002.18 Amital H, Applbaum YH, Bar-On H, Rubinow A. Inside a Charcot joint. Isr Med Assoc J. 5:458-9,2003. 19.Amital H, Ingber A, Rubinow A. Infliximab-induced remission of extensive plaque psoriasis. Isr Med Assoc J 11:827-8,2003.20.Amital H, Aamar S, Rubinow A. Bilateral septic arthritis of the hip: does etanercept play a role? JB&JS 85-A;11:2205-6,2003.21.Elinav H, Maly A, Ilan Y, Rubinow A, Naparstek Y, Amital H. The coexistence of Sweet's syndrome and Still's disease--is it merely a coincidence? J Am Acad Dermatol 50(5 Suppl): S90-2,2004. 22.Amital H, Applbaum YH, Vasiliev L, Rubinow A. Hypertrophic pulmonary osteoarthropathy: control of pain and symptoms with pamidronate. Clin Rheumatol. 23:330-2,2004.23.Mazal B, Amital H, Barkan D, Shaham D, Leitersdorf E. Splenic infarction as an unusual cause of left pleural effusion. Harefuah 143:563-5,2004. (Hebrew)24.Arbel O, Pizov G, Ben-Yehuda A, Rubinow A, Naparstek Y, Amital H. Hyperacute renal failure as the initial presentation of systemic lupus erythematosus. Lupus 14:331-3,2004.25. Ish-Hurwitz S, Dovrish Z, Edelstein E, Bernheim J, Bernheim J, Hadari R, Amital H. Diffuse disseminated Candidiasis in a patient with Felty's syndrome: a case report. Rheumatol Int 28:65-8, 2007. 26. Arnson Y, Dovrish Z, Hadari R, Amital H. Amyopathic dermatomyositis--an uncommon presentation of dermatomyositis. Isr Med Assoc J 9:492-3, 2007.-------------------------------------------------------------------------------------------------------------------27. Khouri S, Kotliroff A, Lishner M, Amital H. Imatinib-lnduced agranulocytosis in a patient with chronic myelogenous leukemia in remission.Isr Med Assoc J. 2008 10:320-1. (IF-0.898, Category- Medicine, General & Internal- 80/132) 28. Eisen A, Dovrish Z, Hadari R, Lew S, Amital H. Jaundice and acute liver failure as the first manifestation of acute myeloid leukemia.Isr Med Assoc J. 2008 10:733-5. (IF-0.898, Category- Medicine, General & Internal- 80/132) Category- Medicine, General & Internal- 85/107) 29. Kasher-Meron M, Uziel Y, Amital H. Successful treatment with B-cell depleting therapy for refractory systemic onset juvenile idiopathic arthritis: a case report. Rheumatology (Oxford). 2009 48:445-6 (IF-4.236, Category-Rheumatology 7/22)30. Arnson Y, Rubinow A, Amital H. Secondary syphilis presenting as SAPHO syndrome features. Clin Exp Rheumatol. 2008 26:1119-21. (IF-2.396, Category-Rheumatology 15/22)31. Goldshmid O, Dovorish Z, Zehavi T, Eisen A, Bar-Dayan Y, Amital H. Coexistent pyoderma gangrenosum and tibialis anterior myositis as presenting manifestations of Crohn's disease: case report and review of the literature. Rheumatol Int. 2009 Oct 22. [Epub ahead of print] (IF-1.493, Category-Rheumatology 19/22)32. Goldenberg G, Eisen A, Weisenberg N, Amital H. Giant left atrium.Isr Med Assoc J. 2009 11:641 (IF-0.898, Category- Medicine, General & Internal- 80/132) 33. Kedar R, Eisen A, Dovrish Z, Hadari R, Lew S, Amital H.Isolated coronary vasculitis as a cause of unexpected sudden death. Isr Med Assoc J. 2009 11:769-70. (IF-0.898, Category- Medicine, General & Internal- 80/132) 34. Plot L, Dovrish Z, Weisenberg N, Amital H. Polycystic kidney and liver disease.Harefuah. 2010;149:118.B.3. Review Articles1.Teplizki H and Dvilansky A. Does platelet derived growth factor (PDGF) induce myelofibrosis in agnogenic myeloid metaplasia? Harefuah 112:102-104,1987. (Hebrew)2.Teplizki H, Kennedy RC and Shoenfeld Y. Vaccine for AIDS-obstacles and approaches to solution. Harefuah 113:354-357,1987. (Hebrew)3.Teplizki H, Slor H and Shoenfeld Y. Clinical significance of antibodies to Ro (SSA) and La (SSB). Harefuah 114:88-90,1988. (Hebrew)4. Avinoach I, Teplizki H, Shoenfeld Y. Serological indicators in systemic lupus erythematosus patients with central nervous system involvement. Harefuah 114:387-390,1988. (Hebrew)5.Teplizki H and Shoenfeld Y. Achievements and progress in medicine - 1987. Harefuah 115:394-396,1988. (Hebrew)6.Shoenfeld Y, Teplizki H, Mendlovic S, Blank M, Mozes E and Isenberg DA. The role of the human anti-DNA idiotype 16/6 in autoimmunity - a short analytical review. Clin Immunol Immunopathol 51:313-325,1989.7. Rotem Y, Amital-Teplizki H and Shoenfeld Y. A recurrent encounter with an old foe-an outbreak of polyomyelitis in Israel - 1988. Viral Immunol 2:57-60,1989.8.Amital-Teplizki H, Shoenfeld Y. Recent advances and developments in medicine.Harefuah 118:609-612,1990. (Hebrew)9.Amital-Teplizki H, Shoenfeld Y. Has schizophrenia an immunological basis? Harefuah 120:392-394,1991. (Hebrew)10.Shoenfeld Y, Zeharhari D, Amital-Teplizki H. Antinuclear antibodies their nature and association with autoimmune diseases. The family physician 20:46-50,1992. (Hebrew)11.Amital H, Shoenfeld Y. Autoimmunity and schizophrenia: an epiphenomenon on an etiology? Isr J Med Sci 29:593-596,1993.12.Amital-Teplizki H, Shoenfeld Y. Early detection of autoimmune diabetes mellitus. Harefuah 126:211-213,1994. (Hebrew)13.Shoenfeld Y, Amital H, Ferrone S, Kennedy RC. Anti-Idiotypes and their application in autoimmune, neoplastic and infectious conditions. Int Arch Allergy Immunol 105:211-223,1994. 14.Amital H. Saponins - an easy way to cope with hyperlipidemia. Harefuah 127:386-388,1994. (Hebrew)15.Amital H, Turcaspa I, Hendler Y, Shoenfeld Y. Catalytic antibodies significance and application. Harefuah 128:295-298,1995. (Hebrew)16.H. Amital, I. Tur-Kaspa, Z. Tashma, I. Hendler, Y. Shoenfeld. Catalytic antibodies-generation nature and possible role as chemical warfare scavengers. Mil Med 161:7-10,1996.17.Y. Bar-Dayan, H Amital, Eldar M. Right ventricular dysplasia. Harefuah 129:464-467,1995. (Hebrew)18.Amital H, Swissa M, Bar-Dayan Y, Buskila D, Shoenfeld Y. (1996) New therapeutic avenues in autoimmunity. Res Immunol, 147:361-376,1996. 18.19. Amital H, Blank M, Shoenfeld Y. Th1/Th2 cells and autoimmunity. Harefuah 131:189-192,1996. (Hebrew)20.Amital H, Shoenfeld Y. Nucleosomes, DNA and SLE: where is the starting point? Clin Exp Rheumatol 14:475-477,1996 .21.Amital H, Levi Y, Shoenfeld Y. Antiphospholipid syndrome and vasculitis – just a coincidence. Harefuah, 134:237-276,1997. (Hebrew)22.Bar-Dayan Y, Gershwin ME, Levi Y, Amital H, Shoenfeld Y. Primary biliary cirrhosis. Is (and how much of) the pathology preventable? Immunol Res 18:117-123,1998,1998. 23.Amital H, Shoenfeld Y. Cytokines, antibodies to cytokines and autoimmunity. Drugs of Today, 825-835,1998.24.Amital H, Shoenfeld Y. Microchimeras – the secret path that leads to autoimmunity? Harefuah, 136:618-620,1999. (Hebrew)25.Leiba A, Amital H, Gershwin ME, Shoenfeld Y. Diet and lupus. Lupus 10:246-248,2001. 26.Amital H, Gilburd B, Shoenfeld Y. Intelligent nutrition: health-promoting mechanisms of probiotics. Isr Med Assoc J 5:812-3,2003. 27.Amital H, Ben-Chetrit E. Therapeutic approaches to familial Mediterranean fever. What do we know and where are we going to? Clin Exp Rheumatol 22(4 Suppl 34):S4-7,2004. Amital H, Eric Gershwin M, Shoenfeld Y. Reshaping the mosaic of autoimmunity.Semin Arthritis Rheum 35:341-3., 2006.Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66:1137-42, 2007. (IF-8.111, Category-Rheumatology 1/22)Rav-Acha M, Plot L, Peled N, Amital H. Coronary involvement in Takayasu's arteritis. Autoimmun Rev 6:566-71, 2007. (IF-6.368, Category-Immunology 14/128)Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Blank M, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Levy Y, Orbach H, Pordeus V, Ram M, Sherer Y, Toubi E, Tomer Y. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases--2008.Isr Med Assoc J. 2008 10:3-7. (IF-0.898, Category- Medicine, General & Internal- 80/132) Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y, Abu-Shakra M, Barzilai O, Berkun Y, Blank M, de Carvalho JF, Doria A, Gilburd B, Katz U, Krause I, Langevitz P, Orbach H, Pordeus V, Ram M, Toubi E, Sherer YThe mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases--2008. Isr Med Assoc J. 2008 10:8-12. (IF-0.898, Category- Medicine, General & Internal- 80/132) 33. Shoenfeld Y, Blank M, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Bizzaro N, Gilburd B, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Mackay IR, Orbach H, Ram M, Sherer Y, Toubi E, Gershwin METhe mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008.Isr Med Assoc J. 2008 10:13-9. (IF-0.898, Category- Medicine, General & Internal- 80/132) 34. Zifman E, Amital H. Prediction of neurological diseases by using autoantibodies: wishful thinking come true.Isr Med Assoc J. 2008 10:29-31. (IF-0.898, Category- Medicine, General & Internal- 80/132) 35. Bassi N, Amital D, Amital H, Doria A, Shoenfeld Y. Chronic fatigue syndrome: characteristics and possible causes for its pathogenesis.Isr Med Assoc J. 2008 10:79-82. (IF-0.898, Category- Medicine, General & Internal- 80/132) 36. Amital H, Govoni M, Maya R, Meroni PL, Ori B, Shoenfeld Y, Tincani A, Trotta F, Sarzi-Puttini P, Atzeni F.Role of infectious agents in systemic rheumatic diseases.Clin Exp Rheumatol. 2008 Jan-Feb;26(1 Suppl 48):S27-32. (IF-2.396, Category-Rheumatology 15/22)37. Eisen A, Arnson Y, Dovrish Z, Hadary R, Amital H. .Arrhythmias and Conduction Defects in Rheumatological Diseases-A Comprehensive Review. Semin Arthritis Rheum. 2009 39:145-56. (IF-4.724, Category-Rheumatology 4/22)38. Plot L, Dovrish Z, Hadari R, Weisenberg N, Zehavi T, Nisenbaum B, Amital H.Cancer of unknown primary site origin--advances in diagnosis and therapy]Harefuah. 2008 147:294-8.39. Zifman E, Amital H, Gilburd B, Shoenfeld Y.Antioxidants and smoking in autoimmune disease--opposing sides of the seesaw?Autoimmun Rev. 2008 8:165-9 (IF-6.368, Category-Immunology 14/128)40. Plot L, Amital H.Infectious associations of Celiac disease.Autoimmun Rev. 2009 8:316-9 (IF-6.368, Category-Immunology 14/128)41. Shoenfeld N, Amital H, Shoenfeld Y. The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol. 2009 5:99-105. (IF-5.533, Category-Rheumatology 3/22)42. Arnson Y, Shoenfeld Y, Alon E, Amital H. The Antiphospholipid Syndrome as a Neurological Disease. Semin Arthritis Rheum. 2009 Jul 12 [Epub ahead of print]. (IF-4.724, Category-Rheumatology 4/22)43. Dovrish Z, Arnson Y, Amital H, Zissin R. Pneumatosis intestinalis presenting in autoimmune diseases: a report of three patients. Ann N Y Acad Sci. 2009 1173:199-202. (IF-2.670, Category-Multidisplinary Sciences 5/42)44. Arnson Y, Shoenfeld Y, Amital H. Intravenous immunoglobulin therapy for autoimmune diseases. Autoimmunity. 2009 42:553-60. (IF-2.813, Category-Immunology 62/128)45. Arnson Y, Amital D, Amital H. The diverse world of vitamin D: does it also modulate pain sensation? Isr Med Assoc J. 2009 11:371-2 (IF-0.898, Category- Medicine, General & Internal- 80/132) 46. Arnson Y, Shoenfeld Y, Amital H.Effects of tobacco smoke on immunity, inflammation and autoimmunity.J Autoimmun. 2010 34:J258-65 (IF-7.231 Category- Immunology - 13/121)47. H. Rosenblum, Y. Bar-Dayan, Z. Dovrish, S. Lew, N. Weisenberg, A. Neumann, T. Klein and H. Amital. The Endless Differential Diagnosis of Acute Obstructive Renal Failure: Unusual Challenges for the Sharp-Sighted Clinician.Isr Med Assoc J. 2010; 12:280-2. (IF-0.898, Category- Medicine, General & Internal- 80/132) ===============================================================B.4. Chapters in books1. Amital-Teplizki H, Shoenfeld Y. The human anti-DNA idiotype (16/6 id) In: Monoclonal antibodies, cytokines and arthritis. (Kresina TF ed) Marcel Dekker Inc,1991.2. Amital Teplizki H, Lymberi P, Tomer Y, Shoenfeld Y. The idiotype network, autoimmunity and natural autoantibodies. In: Natural Autoantibodies, their physiological role and regulatory significance (Shoenfeld Y, Isenberg DA eds.) pp 175-204,1993.3. Amital H, Tur-Kaspa I, Tashma Z, Hendler I, Shoenfeld Y. Catalytic antibodies- structure and possible aplications. In: Methods In Molecular Biology 51- Antibody engineering protocols. (Sudhir P ed.) Humana Press. New Jersey; pp.203-210,1995.4. Amital H, Shoenfeld Y. Autoimmunity and autoimmune diseases such as systemic lupus erythematosus. In: Systemic lupus erythematosus/. (Lahita RG ed.). Academic Press San Diego. pp.1-16,1999.5. Ehrenfeld M, Amital H, Shoenfeld Y. Cytokines, Th1/th2 and Adhesion Molecules in the Antiphospholipid Syndrome. The Antiphospholipid Syndrome. (Asherson RA, Cervera R, Piette J.-C, Shoenfeld y, eds.),2002. 6. Amital H, Shoenfeld Y. Autoimmunity and autoimmune diseases such as systemic lupus erythematosus. In: Systemic lupus erythematosus. (Lahita RG ed.). Academic Press San Diego. pp.3-25,2003.7. Amital H, Shoenfeld Y. The etiopathogenesis of autoimmunity. In: Stem cell therapy in autoimmune diseases. (Burt RK, Marmont AM eds.). Landes Biosciences/. pp. 105-111,2004.8. Amital H, Shoenfeld Y. Natural antibodies, heralding, protecting and inducing autoimmunity. In: Autoantibodies. (Shoenfeld Y, Gershwin ME, Meroni PL eds.) Elsevier. pp. 7-12, 2007.9. Arnson Y, Amital H, Shoenfeld Y. The immunoendocrine role of vitamin D in autoimmunity. In: Endocrine manifestations of systemic autoimmune diseases. (Walker SE, Jara LJ, Asherson RA eds.) Elsevier 7-12, 2007. 293-300, 2008.10. Eisen A, Amital H. adult Still disease. In: Diagnostic criterioa in autoimmune diseases. . (Shoenfeld Y, Cervera R, Gershwin ME eds.)Humana Press pp.25-30, 2008.11. Arnson Y, Dvorish Z, Amital D, Amital H. In: Diagnostic criteria in autoimmune diseases. . (Shoenfeld Y, Cervera R, Gershwin ME eds.)Fibromyalgia syndrome.Humana Press pp.209-216, 2008.12. Itzhaky D, Amital D, Gorden K, Bogomolni A, Amital H. Low serum vitamin D concentrations in patients with schizophrenia. Endocrine conditions in psychiatry, (Lerner V, Miodownik C eds.)Nova Science Publishers Inc. (submitted for publication)G. Other Publications1.Amital H. The first Israeli AIDS conference Tel-Aviv University, January. Harefuah 124:733-734,1993. (Hebrew)2.Amital H. 7th Autoimmunity day in honour of Prof. T Davies, March 20, 1993, Tel-Hashomer. Harefuah 126:50-51,1994. (Hebrew)3.Amital H. 8th Autoimmunity day in honour of E. Gershwin 25 January 1994, Tel-Hashomer. Harefuah 126:756-757,1994. (Hebrew)4.Amital H, Binyamini L Impressions and lessons from the National Forum for Quality in Health--San Francisco, USA December. Harefuah; 140:662,2001. (Hebrew)5. Amital H, Weiss Y. Summary of the medical corps session in the Medax conference, 2001. Isr Med Assoc J; 4:153-50,2002. 6.Amital H. Third Interdisciplinary Symposium on the Treatment of Autoimmune Disorders, 8-10 June 2002, Leipzig, Germany.Isr Med Assoc J ;4 (Suppl):973-6,2002. 7. Carmi G, Amital H.The geoepidemiology of autoimmunity: capsules from the 7th International Congress on Autoimmunity, Ljubljana, Slovenia, May 2010.Isr Med Assoc J. 2011 Feb;13(2):121-7. (IF-0.898, Category- Medicine, General & Internal- 80/132) Letters1. Amital D, Amital H, Gross R, Kindler S and Zohar Y. Sinus bradycardia due to fluvoxamine overdose. BJP 164:553-554,1994. 2.Amital D, Gross R, Amital H, Zohar J. Coexistence of eosinophilia and agranulocytosis in a clozapine-treated patient. Br J Psychiatry 170:194,1997. 3. Amital H, Rubinow A, Langevitz P, Shoenfeld Y. Refractory leg infection as an inducer of the catastrophic antiphospholipid syndrome. Ann Rheum Dis 63:1004,2004. 4.Amital H, Rubinow A. SAPHO syndrome and pamidronate revisited: reply. Rheumatology (Oxford). 44:137-8,2005.5. Glodenberg G, Dovris Z, Amital H. Escitalopram (cipralex) induced prolongation of QT interval. Br J Psychiatry, 2007, . Amital H, Arnson Y, Chodick G, Shalev V. Comment on: Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate: reply. Rheumatology (Oxford). 2009 Oct 14. (IF-4.136, Category-Rheumatology 7/22) ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download